Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
Tizanidine Tablets, LabelThese highlights do not include all the information needed to useSee full prescribing information forInitial U.S. Approval: 1996
Medication labelWhy this: Advisory · dailymed-prescription
TizanidineTablets, USP is a central alpha-2-adrenergic agonist indicated for themanagement of spasticity. Because of the short duration of therapeutic effect,treatment with Tizanidine Tablets, USP should be reserved for those dailyactivities and times when relief of spasticity is most important [see Dosage andAdministration(2.1) ].
- generic_name
- tizanidine
- product_names
- Tizanidine
- ndc
- 63187-673, 57664-503, 63187-673-14, 63187-673-30, 63187-673-60, 63187-673-90
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en